CALL FOR DISCUSSION: PRENATAL-DIAGNOSTICS/bionet.diagnostics.prenatal

BIOSCI Administrator biosci-help at net.bio.net
Tue Feb 28 14:46:05 EST 1995


We have received a proposal below for a new newsgroup,

PRENATAL-DIAGNOSTICS/bionet.diagnostics.prenatal

Discussion on the following proposal will now be open through 9 March
on BIOFORUM/bionet.general (*not* on BIONEWS/bionet.announce).  For
those who are not on the BIOFORUM/bionet.general newsgroup currently,
either read bionet.general on USENET or contact one of the following
biosci addresses to sign up by e-mail:

Subscription Address                 Location
--------------------                 --------
biosci at daresbury.ac.uk               Europe, Africa, and Central Asia
biosci at net.bio.net                   Americas and the Pacific Rim

One warning, however: BIOFORUM/bionet.general is a "chatty" newsgroup
and many other items will be discussed there besides this newsgroup
proposal.  USENET news access is definitely better than e-mail if you
want to monitor only this discussion.

Discussion Guidelines
---------------------
Please do not post one-line messages saying things like "I am in favor
of such a newsgroup".  We will collect votes later.  The discussion
period is an opportunity for anyone to bring up reservations about the
proposed charter below and to propose modifications prior to the vote.
If the charter is perfect as is, then there is no need for anyone to
say anything!!!

The newsgroup discussion leader may submit a revised proposal in light
of the discussion, and the new charter would be included in the call
for votes which will go out on 10 March (Newsgroup Discussion
leaders - please note this deadline - if no revisions are received
before the deadline, the original charter will be voted on.).

Please be aware that only one vote is counted per e-mail address, so
it is necessary to have your own account in order to vote.  Multiple
votes from the same address are not accepted.  If you are interested
in the following newsgroup, but do not have an e-mail address of your
own, please obtain one from your computer center before the call for
votes is issued.

----------------------------------------------------------------------
Proposal to etablish PRENATAL-DIAGNOSTICS/bionet.diagnostics.prenatal

Proposed USENET name:       bionet.diagnostics.prenatal

Proposed mailing list name: PRENATAL-DIAGNOSTICS

Proposed e-mail addressess: prenatal at net.bio.net
                            prenatal at daresbury.ac.uk

Discussion leaders:         Aneal Chandra
                            Chandra at cardiff.ac.uk

                            David Miller
                            Davidm at pathology.leeds.ac.uk

                            Tim Reynolds
                            Timreyno at burton.demon.co.uk

Cytogenetic testing is a relatively common procedure during
pregnancy to examine the health of the fetus. At the present time,
amniocentesis is often used to obtain fetal cells for the testing.
Amniocentesis is an expensive, invasive and potentially harmful
procedure. Therefore selection of patients for amniocentesis by
biochemical risk screeening tests has developed, and research into
alternative procedures is actively being pursued.

One avenue for this research is extraction of fetal cells from the
maternal circlation. It is clear that a small number of fetal cells
cross the placental barrier and sevaral approaches to identifying,
extracting, concentrating and analysing these rare fetal cells are
under evaluation.

In addition serving a bulletin board for announcements of meetings,
conferences, job opportunities, and funding sources of interest to
biologists researching this dynamic field, bionet.diagnostics.prenatal
is intended to provide an easy access environment facilitating:

* rapid exchange of technical information between researchers in
prenatal diagnostics, clinical chemistry, cytogenetics and other
associated areas.

* co-operation between clinical laboratories, research biologists
and instrument designers permitting the technological refinements
necessary for the successful implementation of new and safer
procedures

* discussion of the logistical and social impact of new technology
in prenatal diagnosis

Subscribers are welcome from academic and commercial institutions
including but not limited to developmental biology, cytogenetics,
haematology, pathology, immunology, cell biology, epidemiology,
obstetrics and paediatrics. Contributions within the functions
outlined above are encouraged. The newsgroup is expected to run
in an unmoderated fashion and we are willing to act as current
coordinators.

Aneal Chandra
Scientist, Cytogentics Unit for Wales, UK

David Miller
Lecturer, Institute of Pathology, Leeds, UK

Tim Reynolds
Consultant, Clinical Chemistry, Burton General Hospital, UK
----------------------------------------------------------------------



More information about the Bioforum mailing list